Approval · Notice of Compliance 4300 · 1996

CLAFORAN: Notice of Compliance 4300

Issued July 17, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 4300
Date: July 17, 1996
Company: Hoechst Marion Roussel Canada Inc.Laval, Quebec, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Therapeutic class: Antibiotic

Products in this notice

Brand	DIN	Status today
CLAFORAN	02225085	Cancelled Post Market
CLAFORAN	02225093	Cancelled Post Market
CLAFORAN	02225107	Cancelled Post Market
CLAFORAN	02225115	—

Medicinal ingredients

CEFOTAXIME SODIUM 500 MG per VIAL
CEFOTAXIME SODIUM 1 G per VIAL
CEFOTAXIME SODIUM 2 G per VIAL